“A Prospective Clinical Study for Safety and Efficacy of Intralesional Tuberculin Purified Protein Derivative in Treatment of Palmoplantar Verruca”. Journal of Nobel Medical College 11, no. 1 (June 29, 2022): 12–16. Accessed July 5, 2026. https://nepjol.info/index.php/JoNMC/article/view/45720.